vs
Side-by-side financial comparison of AdvanSix Inc. (ASIX) and TRIMAS CORP (TRS). Click either name above to swap in a different company.
AdvanSix Inc. is the larger business by last-quarter revenue ($359.9M vs $256.5M, roughly 1.4× TRIMAS CORP). TRIMAS CORP runs the higher net margin — 31.9% vs -0.8%, a 32.6% gap on every dollar of revenue. On growth, AdvanSix Inc. posted the faster year-over-year revenue change (9.4% vs 3.8%). TRIMAS CORP produced more free cash flow last quarter ($36.8M vs $36.1M). Over the past eight quarters, AdvanSix Inc.'s revenue compounded faster (3.4% CAGR vs 3.3%).
AdvanSix Inc. is an American chemical company that produces nylon 6 and related chemicals such as caprolactam and ammonium sulfate fertilizers. It operated as Honeywell's Resins and Chemicals division until 2016, when it was spun off as a separate company. The unit accounted for 3 percent of Honeywell's sales at the time. For 2019, revenue is estimated at $1.4 billion. The company traces its lineage to the H. W. Jayne Company, established 1884 in Frankford, Pennsylvania.
Trimas Corp is a diversified industrial manufacturing enterprise that designs, produces and distributes a wide portfolio of engineered products, including specialized fasteners, aerospace components, custom packaging solutions, and consumer & industrial hardware. It primarily serves aerospace, automotive, construction, consumer goods and industrial sectors, with core operations across North America and selected global markets.
ASIX vs TRS — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $359.9M | $256.5M |
| Net Profit | $-2.8M | $81.7M |
| Gross Margin | 7.6% | 12.8% |
| Operating Margin | -0.7% | 5.7% |
| Net Margin | -0.8% | 31.9% |
| Revenue YoY | 9.4% | 3.8% |
| Net Profit YoY | -892.9% | 236.9% |
| EPS (diluted) | $-0.11 | $2.03 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $256.5M | ||
| Q4 25 | $359.9M | $-140.0M | ||
| Q3 25 | $374.5M | $269.3M | ||
| Q2 25 | $410.0M | $274.8M | ||
| Q1 25 | $377.8M | $241.7M | ||
| Q4 24 | $329.1M | $-66.2M | ||
| Q3 24 | $398.2M | $229.4M | ||
| Q2 24 | $453.5M | $240.5M |
| Q1 26 | — | $81.7M | ||
| Q4 25 | $-2.8M | $81.7M | ||
| Q3 25 | $-2.6M | $9.3M | ||
| Q2 25 | $31.4M | $16.7M | ||
| Q1 25 | $23.3M | $12.4M | ||
| Q4 24 | $352.0K | $5.6M | ||
| Q3 24 | $22.3M | $2.5M | ||
| Q2 24 | $38.9M | $10.9M |
| Q1 26 | — | 12.8% | ||
| Q4 25 | 7.6% | — | ||
| Q3 25 | 6.8% | 12.8% | ||
| Q2 25 | 14.3% | 13.8% | ||
| Q1 25 | 14.2% | 13.6% | ||
| Q4 24 | 3.4% | — | ||
| Q3 24 | 14.4% | 15.4% | ||
| Q2 24 | 17.9% | 14.4% |
| Q1 26 | — | 5.7% | ||
| Q4 25 | -0.7% | — | ||
| Q3 25 | -0.9% | 6.2% | ||
| Q2 25 | 7.7% | 9.9% | ||
| Q1 25 | 7.7% | 9.0% | ||
| Q4 24 | -3.9% | — | ||
| Q3 24 | 7.5% | 3.6% | ||
| Q2 24 | 11.5% | 7.4% |
| Q1 26 | — | 31.9% | ||
| Q4 25 | -0.8% | -58.4% | ||
| Q3 25 | -0.7% | 3.5% | ||
| Q2 25 | 7.7% | 6.1% | ||
| Q1 25 | 6.2% | 5.1% | ||
| Q4 24 | 0.1% | -8.5% | ||
| Q3 24 | 5.6% | 1.1% | ||
| Q2 24 | 8.6% | 4.5% |
| Q1 26 | — | $2.03 | ||
| Q4 25 | $-0.11 | $2.01 | ||
| Q3 25 | $-0.10 | $0.23 | ||
| Q2 25 | $1.15 | $0.41 | ||
| Q1 25 | $0.86 | $0.30 | ||
| Q4 24 | $0.02 | $0.14 | ||
| Q3 24 | $0.82 | $0.06 | ||
| Q2 24 | $1.43 | $0.27 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $19.8M | $30.0M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $815.2M | $705.6M |
| Total Assets | $1.7B | $1.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $30.0M | ||
| Q4 25 | $19.8M | $30.0M | ||
| Q3 25 | $23.7M | $33.6M | ||
| Q2 25 | $18.4M | $30.3M | ||
| Q1 25 | $8.3M | $32.7M | ||
| Q4 24 | $19.6M | $23.1M | ||
| Q3 24 | $17.3M | $26.9M | ||
| Q2 24 | $12.1M | $35.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | $469.2M | ||
| Q3 25 | — | $407.1M | ||
| Q2 25 | — | $424.5M | ||
| Q1 25 | — | $434.2M | ||
| Q4 24 | — | $398.1M | ||
| Q3 24 | — | $409.9M | ||
| Q2 24 | — | $427.4M |
| Q1 26 | — | $705.6M | ||
| Q4 25 | $815.2M | $705.6M | ||
| Q3 25 | $818.2M | $725.0M | ||
| Q2 25 | $823.7M | $715.3M | ||
| Q1 25 | $794.4M | $686.6M | ||
| Q4 24 | $774.6M | $667.3M | ||
| Q3 24 | $766.4M | $682.8M | ||
| Q2 24 | $746.6M | $675.9M |
| Q1 26 | — | $1.5B | ||
| Q4 25 | $1.7B | $1.5B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.6B | $1.4B | ||
| Q1 25 | $1.6B | $1.4B | ||
| Q4 24 | $1.6B | $1.3B | ||
| Q3 24 | $1.5B | $1.4B | ||
| Q2 24 | $1.5B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | 0.56× | ||
| Q2 25 | — | 0.59× | ||
| Q1 25 | — | 0.63× | ||
| Q4 24 | — | 0.60× | ||
| Q3 24 | — | 0.60× | ||
| Q2 24 | — | 0.63× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $63.7M | $117.5M |
| Free Cash FlowOCF − Capex | $36.1M | $36.8M |
| FCF MarginFCF / Revenue | 10.0% | 14.4% |
| Capex IntensityCapex / Revenue | 7.7% | 18.9% |
| Cash ConversionOCF / Net Profit | — | 1.44× |
| TTM Free Cash FlowTrailing 4 quarters | $6.4M | $109.7M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $117.5M | ||
| Q4 25 | $63.7M | $41.5M | ||
| Q3 25 | $26.6M | $36.5M | ||
| Q2 25 | $21.1M | $30.3M | ||
| Q1 25 | $11.4M | $9.2M | ||
| Q4 24 | $64.2M | $27.1M | ||
| Q3 24 | $57.3M | $22.0M | ||
| Q2 24 | $50.2M | $18.4M |
| Q1 26 | — | $36.8M | ||
| Q4 25 | $36.1M | $36.8M | ||
| Q3 25 | $66.0K | $22.8M | ||
| Q2 25 | $-7.2M | $13.2M | ||
| Q1 25 | $-22.6M | $-3.8M | ||
| Q4 24 | $29.8M | $12.1M | ||
| Q3 24 | $26.8M | $10.2M | ||
| Q2 24 | $16.7M | $7.5M |
| Q1 26 | — | 14.4% | ||
| Q4 25 | 10.0% | -26.3% | ||
| Q3 25 | 0.0% | 8.5% | ||
| Q2 25 | -1.7% | 4.8% | ||
| Q1 25 | -6.0% | -1.6% | ||
| Q4 24 | 9.1% | -18.3% | ||
| Q3 24 | 6.7% | 4.4% | ||
| Q2 24 | 3.7% | 3.1% |
| Q1 26 | — | 18.9% | ||
| Q4 25 | 7.7% | -3.4% | ||
| Q3 25 | 7.1% | 5.1% | ||
| Q2 25 | 6.9% | 6.2% | ||
| Q1 25 | 9.0% | 5.4% | ||
| Q4 24 | 10.4% | -22.6% | ||
| Q3 24 | 7.7% | 5.2% | ||
| Q2 24 | 7.4% | 4.5% |
| Q1 26 | — | 1.44× | ||
| Q4 25 | — | 0.51× | ||
| Q3 25 | — | 3.92× | ||
| Q2 25 | 0.67× | 1.81× | ||
| Q1 25 | 0.49× | 0.74× | ||
| Q4 24 | 182.29× | 4.80× | ||
| Q3 24 | 2.57× | 8.71× | ||
| Q2 24 | 1.29× | 1.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
TRS
Segment breakdown not available.
